找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiotherapy in Skin Cancer; A Practical Guide on Kurian Jones Joseph,Michael J. Veness,Agata Rembie Book 2023 The Editor(s) (if applicable

[復(fù)制鏈接]
樓主: Concave
21#
發(fā)表于 2025-3-25 06:28:26 | 只看該作者
22#
發(fā)表于 2025-3-25 09:43:00 | 只看該作者
Lipry and primary radical radiotherapy are equal treatment modalities for early-stage carcinomas; adjuvant radiotherapy improves outcomes for those with lip carcinomas with high-risk features..The evidence base lacks prospective data on patient-reported outcome measures and quality-of-life metrics; dat
23#
發(fā)表于 2025-3-25 15:08:48 | 只看該作者
Ear ear is a high-risk region for locoregional recurrence. Treatment planning can be challenging given the irregular surface contours of the ear. Treatment may be delivered with kilovoltage, electrons, photons, and brachytherapy depending on the site of disease presentation.
24#
發(fā)表于 2025-3-25 18:41:12 | 只看該作者
25#
發(fā)表于 2025-3-25 20:40:00 | 只看該作者
Primary Melanoma and Lentigo Maligna after complete excision of a primary melanoma to reduce local recurrence based on certain pathological indications. RT is rarely used as the primary treatment for certain patients with unresectable primary melanoma after multidisciplinary team discussion. For lentigo maligna, RT is an acceptable no
26#
發(fā)表于 2025-3-26 00:08:26 | 只看該作者
Merkel Cell Carcinomaere on the body, and most (50–60%) patients present with a primary lesion with the incidence of subclinical nodal spread high (30–50%). There is an extensive body of evidence supporting the addition of adjuvant radiotherapy in improving locoregional control and survival. Patients are often not suita
27#
發(fā)表于 2025-3-26 07:49:57 | 只看該作者
28#
發(fā)表于 2025-3-26 11:58:38 | 只看該作者
Regional Radiotherapy in Head and Neck Non-melanoma Skin Cancernd neck region. Optimal management of NMSC with metastatic regional disease involves surgery and adjuvant radiotherapy (RT). Elective nodal RT may occasionally be considered in select cases with a high-risk primary character. The addition of chemotherapy to RT in locoregionally advanced cutaneous sq
29#
發(fā)表于 2025-3-26 13:22:43 | 只看該作者
30#
發(fā)表于 2025-3-26 19:30:50 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 01:40
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
鹿邑县| 延川县| 满城县| 札达县| 醴陵市| 浑源县| 重庆市| 凯里市| 大名县| 古丈县| 延寿县| 岳池县| 开鲁县| 普定县| 布拖县| 灯塔市| 青铜峡市| 双城市| 太仓市| 连江县| 灵台县| 南和县| 曲沃县| 滦平县| 图木舒克市| 探索| 上高县| 墨竹工卡县| 揭阳市| 治多县| 襄汾县| 巴里| 澄城县| 宝应县| 舒兰市| 衡阳市| 绩溪县| 宣恩县| 磐安县| 吉水县| 习水县|